Locate is based in MediCity and has developed a family of unique, thermally-activated, injectable scaffolds that solidify within the body and can be used to support tissue growth before degrading away.
DATE FIRST INVESTED
The TAOSTM (Targeted, Orchestrated Signalling) technology is a world first in tissue repair and enables the precision focus of therapeutic signals from small molecule or biological actives at the site of repair. TAOSTM has many potential application sites across the body.
Pipeline technology includes RPMax, a thermo-reversible matrix, and IntraStem, a new delivery system for cells; technologies that can meet industry recognised needs to advance cell therapy markets such as transfection, genome editing and induced pluripotent stem cells.